Big biomedical data and cardiovascular disease research: Opportunities and challenges

European Heart Journal - Quality of Care and Clinical Outcomes

Volumn 1, Issue 1, 2015, Pages 9-16

  Denaxas, Spiros C ^a   Morley, Katherine I ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Big data; Electronic health records; Electronic medical records; Epidemiology; Translational research

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATRIAL FIBRILLATION; BIOINFORMATICS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL RESEARCH; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; ELECTRONIC HEALTH RECORD; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MEDICAL INFORMATICS; MORTALITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; TRAINING; TRANSLATIONAL RESEARCH;

EID: 85017310083     PISSN: 20585225     EISSN: 20581742     Source Type: Journal    
DOI: 10.1093/ehjqcco/qcv005     Document Type: Review

References (62)

1. Community cleverness required. Nature 2008;455:1.
2. Challenges and Opportunities: American Association for the Advancement of Science. Science 2011; 331:692-693.
3. Weber G, Mandl K, Kohane I. Finding the Missing Link for Big Biomedical Data. JAMA 2014;311:2479-2480.
4. Jensen P, Jensen L, Brunak S. Mining electronic health records: towards better research applications and clinical care. Nat Rev Genet 2012;13:395-405.
5. Khoury M,Lam TK, Ioannidis J, Hartge P, Spitz M, Buring J et al. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev 2013;22:508-516.
6. Collins F, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372: 793-795.
7. 100,000 Genomes Project. http://www.genomicsengland.co.uk/ (26 March 2014).
8. Margolis R, Derr L, Dunn M, Huerta M, Larkin J, Sheehan J, Guyer M, Green ED. The National Institutes of Healths Big Data to Knowledge (BD2 K) initiative: capitalizing on biomedical big data. J Am Med Inform Assoc 2014;21:957-958.
9. Farr Institute for Health Informatics Research. http://www.farrinstitute.org (26 March 2014).
10. Richards N, King J. Big Data Ethics. In: Social Science Research NetworkWorking Paper Series. 2014.
11. Boyd D, Crawford K. Critical questions for big data. Inf, Commun Soc 2012;15: 662-679.
12. World Health Organization. International Classification of Diseases (ICD). http:// apps.who.int/classifications/icd10/browse/2015/en (26 March 2014).
13. Stearns MQ, Price C, Spackman KA,WangAY.SNOMEDclinical terms: overview of the development process and project status. In: Proceedings of the American Medical Informatics Association Symposium. 2001:662-666.
14. Wang Z, Shah A, Tate R, Denaxas S, Shawe-Taylor J, Hemingway H. Extracting diagnoses and investigation results from unstructured text in electronic health records by semi-supervised machine learning. PLoS ONE 2012;7:e30412.
15. Petersen S, Selvanayagam J, Wiesmann F, Robson M, Francis J, Anderson R, Watkins H, Neubauer S. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-105.
16. Timmis A, Feder G, HemingwayH. Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 2007;93:786-791.
17. Chung S-C, Gedeborg R, Nicholas O, James S, Jeppsson A,Wolfe C, Heuschmann P, Wallentin L, Deanfield J, Timmis A, Jernberg T, Hemingway H. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet 2014;383:1305-1312.
18. Singh S, Loke Y, Spangler J, Furberg C. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. Can Med Assoc J 2011;183:1359-1366.
19. Mills E, Thorlund K, Eapen S, Wu P, Prochaska J. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation 2014;129:28-41.
20. Prochaska J, Hilton J. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ 2012;344:e2856.
21. Ware J, Vetrovec G, Miller A, Van Tosh A, Gaffney M, Yunis C, Arteaga C, Borer JS. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials. Am J Ther 2013;20:235-246.
22. Prochaska J, Hilton J. Vareniclines adverse events.Choice of summary statistics: relative and absolute measures. BMJ 2013;346: doi:10.1136/bmj.f1092.
23. Krebs P, Sherman S. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events. Ann Intern Med 2012;157: doi: 7326/0003-4819-157-4-201208210-02002.
24. SvanstromH, Pasternak B, Hviid A. Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study. BMJ 2012;345:e7176.
25. Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol 2015;12:230-243.
26. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038.
27. Kim S, Liu J, Solomon D. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis 2014;73:1091-1095.
28. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, Torp-Pedersen C, Hansen PR. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 2012;344:e1257.
29. Parisi R, Rutter M, Lunt M, Young H, Symmons DP, Griffiths CE, Ashcroft DM. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 2015; doi: 10.1038/jid.2015.87.
30. Ahlehoff O, Gislason G, Jorgensen C, Lindhardsen J, Charlot M, Olesen J, Abildstrom SZ, Skov L, Torp-Pedersen C, Hansen PR. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2012;33:2054-2064.
31. Jensen AB, Moseley P, Oprea T, Ellesoe SG, Eriksson R, Schmock H, Jensen PB, Jensen LJ, Brunak S. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nat Commun 2014;5:1-11, doi: 10.1038/ ncomms5022.
32. Morris Z,Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104:510-520.
33. Scannell J, Blanckley A, Boldon H,Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 2012;11:191-200.
34. The Truly Staggering Cost Of Inventing New Drugs - Forbes. http://www.forbes. com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-invent ing-new-drugs/ (26 March 2014).
35. Stuart E, Cole S, Bradshaw C, Leaf P. The use of propensity scores to assess the generalizability of results from randomized trials. J R Stat Soc Ser A Stat Soc 2011;174: 369-386.
36. Ezekowitz J, Hu J, Delgado D, Hernandez A, Kaul P, Leader R, Proulx G, Virani S, White M, Zieroth S, OConnor C, Westerhout CM, Armstrong PW. Acute heart failure. Circ Heart Fail 2012;5:735-741.
37. Keene D, Price C, Shun-Shin M, Francis D. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients. BMJ 2014;349:g4379.
38. Fox K, Ford I, Steg P, Tardif J-C, Tendera M, Ferrari R. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014;371:1091-1099.
39. New J, Bakerly N, Leather D, Woodcock A. Obtaining real-world evidence: the Salford Lung Study. Thorax 2014;371:1091-1099.
40. Frobert O, Lagerqvist B, Olivecrona G, Omerovic E, Gudnason T, Maeng M, Aasa M, Angeras O, Calais F, Danielewicz M, Erlinge D, Hellsten L, Jensen U, Johansson AC, Karegren A, Nilsson J, Robertson L, Sandhall L, Sjogren I, Ostlund O, Harnek J, James SK; TASTE Trial. Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction. N Engl J Med 2013;369:1587-1597.
41. Ford I, MurrayH, Packard C, Shepherd J, Macfarlane P, Cobbe S. Long-Term Followup of the West of Scotland Coronary Prevention Study. N Engl J Med 2007;357: 1477-1486.
42. van Staa T-P, Dyson L, McCann G, Padmanabhan S, Belatri R, Goldacre B, Cassell J, Pirmohamed M, Torgerson D, Ronaldson S, Adamson J, Taweel A, Delaney B, Mahmood S, Baracaia S, Round T, Fox R, Hunter T, Gulliford M, Smeeth L. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess 2014;18:1-146.
43. van Staa T-P, Goldacre B, Gulliford M, Cassell J, PirmohamedM, Taweel A, Delaney B, Smeeth L. Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ 2012;344:e55.
44. Castillo T, Arofan G, Moore S, Hole B, McMahon C, Denaxas S, van Den Eyden V, LHours L, Bell L, Kneeshaw J, Woollard M, Kanjala C, Knight G. Enhancing discoverability of public health and epidemiology. 2014. http://www.wellcome. ac.uk/About-us/Policy/Spotlight-issues/Data-sharing/Public-health-andepidemiology/ WTP054675.htm (26 March 2014).
45. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012;3:89-99.
46. Hospital Episode Statistics. Health & Social Care Information Centre.
47. Herrett E, Smeeth L, Walker L, Weston C, on behalf of the MAG. The Myocardial Ischaemia National Audit Project (MINAP). Heart 2010;96:1264-1267.
48. Mortality Statistics: Deaths Registered in England and Wales (Series DR), 2010 - ONS. http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics-deathsregistered- in-england-and-wales-series-dr-/2010/index.html (26 March 2014).
49. Herrett E, Shah A, Boggon R, Denaxas S, Smeeth L, van Staa T, Timmis A, Hemingway H. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013;346:f2350.
50. Morley K, Wallace J, Denaxas S, Hunter R, Patel R, Perel P, Shah AD, Timmis AD, Schilling RJ, Hemingway H. Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation. PLoS ONE 2014;9:e110900.
51. Pathak J, Kho A, Denny J. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. J Am Med Inform Assoc 2013;20:e206-11.
52. Chen Y, Carroll R, Hinz EM, Shah A, Eyler A, Denny J et al. Applying active learning to high-throughput phenotyping algorithms for electronic health records data. J Am Med Inform Assoc 2013;20:e253-9.
53. Mohebbi M, Ghassemian H, eds. Detection of atrial fibrillation episodes using SVM. Engineering in Medicine and Biology Society, 2008 EMBS 2008 30th Annual International Conference of the IEEE. IEEE 2008.
54. Gottesman O, Kuivaniemi H, Tromp G, Faucett A, Li R, Manolio T, Sanderson SC, Kannry J, Zinberg R, Basford MA, Brilliant M, Carey DJ, Chisholm RL, Chute CG, Connolly JJ, Crosslin D, Denny JC, Gallego CJ, Haines JL, Hakonarson H, Harley J, Jarvik GP, Kohane I, Kullo IJ, Larson EB, McCarty C, Ritchie MD, Roden DM, Smith ME, Bo ttinger EP, Williams MS; eMERGE Network. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med 2013;15:761-771.
55. Kho AN, Pacheco JA, Peissig PL, Rasmussen L, Newton KM,Weston N, Crane PK, Pathak J, Chute CG, Bielinski Sj, Kullo IJ, Li R, Manolio TA, Chisholm RL, Denny JC. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med 2011;3:79re1.
56. Ko hler S, Doelken SC, Mungall CJ, Bauer S, Firth HV, Bailleul-Forestier I, Black GC, Brown DL, Brudno M, Campbell J, FitzPatrick DR, Eppig JT, Jackson AP, Freson K, Girdea M, Helbig I, Hurst JA, Jahn J, Jackson LG, Kelly AM, Ledbetter DH, Mansour S, Martin CL, Moss C, Mumford A, Ouwehand WH, Park SM, Riggs ER, Scott RH, Sisodiya S, Van Vooren S,Wapner RJ, Wilkie AO, Wright CF, Vulto-van Silfhout AT, de Leeuw N, de Vries BB, Washingthon NL, Smith CL, Westerfield M, Schofield P, Ruef BJ, Gkoutos GV, Haendel M, Smedley D, Lewis SE, Robinson PN, The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res, 2014, 42(Database issue) D966-D974.
57. Ritchie MD, Denny JC, Crawford DC, Ramirez AH, Weiner JB, Pulley JM, Basford MA, Brown-Gentry K, Balser JR, Masys DR, Haines JL, Roden DM. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010;86:560-572.
58. Newton K, Peissig P, Kho A, Bielinski S, Berg R, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013;20: e147-e154.
59. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale C, Deanfield J, Smeeth L, Timmis A, Hemingway H. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabet Endocrinol 2015;3:105-113.
60. Khoury M, Gwinn M, Ioannidis J. The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 2010;172: 517-524.
61. Denaxas S, George J, Herrett E, Shah A, Kalra D, Hingorani A, Kivimaki M, Timmis AD, Smeeth L, Hemingway H. Data Resource Profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012;41:1625-1638.
62. Stewart R, Soremekun M, Perera G, Broadbent M, Callard F, Denis M, Hotopf M, Thornicroft G, Lovestone S. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 2009;9:51.